Skip to main content
Midas Edge

Incannex Healthcare Inc

For the period ended Mar 31, 2025. Filed May 15, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 15, 2025

IXHL$2.01-8.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Operations and Comprehensive Loss

For the three months ended March 31,For the 9 months ended March 31,
2025202420252024
Revenue from customers--86-
Operating expenses:
Research and development(2,735)(3,277)(7,045)(8,520)
General and administrative(2,268)(4,138)(9,302)(11,777)
Total operating expenses(5,003)(7,415)(16,347)(20,297)
Loss from operations(5,003)(7,415)(16,261)(20,297)
Other income, net:----
R&D tax incentive4211,3202,1888,150
Foreign exchange gains/(losses)41(11)(290)(17)
Interest income47560166
Interest expense(132)-(303)-
Loss on change in fair value of convertible rights--(179)-
Gain on change in fair value of warrant liabilities1,824-1,721-
Warrant issuance costs(129)-(129)-
Loss on extinguishment(994)-(994)-
Other expenses--(1,095)-
Total other income, net1,0351,3849798,299
Loss before income tax expense(3,968)(6,031)(15,282)(11,998)
Income tax expense----
Net loss$(3,968)$(6,031)$(15,282)$(11,998)
Other comprehensive income/(loss):
Currency translation adjustment, net of tax(88)(820)(163)(403)
Total comprehensive loss$(4,056)$(6,851)$(15,445)$(12,401)
Net loss per share: Basic and diluted$(0.20)$(0.38)$(0.84)$(0.76)
Weighted average number of shares outstanding, basic and diluted19,632,53915,873,11318,238,86315,873,113
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.